Trial Profile
A phase 3, multicenter, randomized, double-blind, comparative study of the efficacy and safety of intravenous tigecycline vs intravenous levofloxacin to treat subjects hospitalized with community-acquired pneumonia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Feb 2013
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary) ; Levofloxacin
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Registrational; Therapeutic Use
- 06 Jul 2007 Status changed from in progress to completed.
- 29 Sep 2005 New trial record.